Characterization of Early Disease Status in Treatment-Naive Male Paediatric Patients with Fabry Disease Enrolled in a Randomized Clinical Trial
Fig 1
Skin GL-3 scores in treatment-naive male paediatric patients with Fabry disease.
Data missing for deep vessel endothelial cells (n = 2), deep vessel smooth muscle cells (n = 17), and perineurium (n = 3); cell types not present in biopsy. GL-3 = globotriaosylceramide.